Injectable Drug Delivery - Global Market Outlook (2016-2022)

  • ID: 4428526
  • Report
  • Region: Global
  • 158 pages
  • Stratistics Market Research Consulting Pvt Ltd
1 of 4

FEATURED COMPANIES

  • Alkermes PLC
  • Elcam Medical
  • ELI Lilly and Company
  • Gerresheimer AG
  • Novo Nordisk
  • Pfizer, Inc.
  • MORE
According to MRC, the Global Injectable Drug Delivery market is accounted for $348.64 billion in 2015 and is expected to reach $866.31 billion by 2022 growing at a CAGR of 13.9%. Rising incidences of chronic diseases, technological advancements and increase in demand for self injection devices are some of the factors proliferating market demand. However, factors such as needle-stick injuries and lack of access to or failure to use appropriate personal protective equipment are some factors inhibiting the market.

Oncology and Hormonal disorder segment among therapeutic applications is expected to dominate the market owing to the rising number of patients suffering from diabetes and oncologic disorders. Moreover, self-injection device segment in product type is estimated to be the fastest growing segment on account of growing geriatric people coupled with diabetic patients. North American market is estimated to be the dominant among others attributed to its huge patient base and healthcare sector. Asia Pacific is expected to be the fastest growing market on account of its emerging healthcare sector.

Some of the key players of the Injectable Drug Delivery market include Alkermes PLC, Baxter International, Inc., Becton, Dickinson and Company, Elcam Medical, ELI Lilly and Company, Gerresheimer AG, Nov-Nordisk, Pfizer, Inc., Sandoz, Schott AG, Terum-Corporation and Teva Pharmaceutical Industries Ltd.

Therapeutic
Applications Covered:
  • Autoimmune Diseases
  • Crohn’s Disease
  • Multiple Sclerosis
  • Psoriasis
  • Rheumatoid Arthritis
  • Other Autoimmune Diseases
  • Hormonal Disorders
  • Anaemia
  • Antithrombotic/Thrombolytic Therapy
  • Diabetes
  • Growth Hormone Deficiency (GHD)
  • Osteoporosis
  • Reproductive Health Disease
  • Orphan Diseases
  • Oncology
  • Other Therapeutic Applications
  • Pain Management
  • Allergy Treatment
  • Aesthetic Treatments
  • Hepatitis C
  • Haemophilia
End-Users Covered:
  • Home Care Settings
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Research Laboratories
  • Other End Users
Types Covered:
  • Auto-injectors
  • Reusable Auto-injectors
  • Disposable Auto-injectors
  • Product Specific Auto-injectors
  • Pen Injectors
  • Custom Pen Designs
  • Disposable Pens
  • Dual Chamber Pens
  • Prefilled Pen Cartridges
  • Standardized Pen Platforms
  • Needle-free Injectors
  • Mass Immunization Injectors
  • Prefilled Disposable Models
  • Refillable Cartridge Designs
  • Energy Source
  • Jeto Based Needle-Free Injectors
  • Spring-Based Needle-Free Injectors
  • Laser-Powered Needle-Free Injectors
  • Vibration-Based Needle-Free Injectors
  • Prefilled Syringes
  • Plastic Prefilled Syringes
  • Glass Prefilled Syringes
  • Pre-fillable Safety Syringes
  • Safety Syringes
  • Pre-fillable Integrated Safety Syringes
  • Non-Pre-fillable Integrated Safety Syringes
  • Conventional Injection Devices
Formulations Covered:
  • Novel Drug Delivery Formulations
  • Colloidal Dispersions
  • Micr-particles
  • Long-Acting Injection Formulations
  • Conventional Drug Delivery
  • Solutions
  • Reconstituted/Lyophilized Formulations
  • Suspensions
  • Emulsions
Modes of Administration Covered:
  • Central Nervous System
  • Circulatory/Musculoskeletal
  • Organs
  • Skin
Usage Patterns Covered:
  • Curative Care
  • Immunization
  • Other Usage Patterns
  • Blood Transfusion & Blood Products
  • Contraceptives
Regions Covered:
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Italy
  • UK
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • Rest of Asia Pacific
  • Rest of the World
  • Middle East
  • Brazil
  • Argentina
  • South Africa
  • Egypt
What The Report Offers:
  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Alkermes PLC
  • Elcam Medical
  • ELI Lilly and Company
  • Gerresheimer AG
  • Novo Nordisk
  • Pfizer, Inc.
  • MORE
1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End-User Analysis
3.8 Product Analysis
3.9 Emerging markets
3.10 Futuristic market scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Injectable Drug Delivery Market, By Therapeutic Application
5.1 Introduction
5.2 Autoimmune Diseases
5.2.1 Crohn’s Disease
5.2.2 Multiple Sclerosis
5.2.3 Psoriasis
5.2.4 Rheumatoid Arthritis
5.2.5 Other Autoimmune Diseases
5.3 Hormonal Disorders
5.3.1 Anaemia
5.3.2 Antithrombotic/Thrombolytic Therapy
5.3.3 Diabetes
5.3.4 Growth Hormone Deficiency (GHD)
5.3.5 Osteoporosis
5.3.6 Reproductive Health Disease
5.4 Orphan Diseases
5.5 Oncology
5.6 Other Therapeutic Applications
5.6.1 Pain Management
5.6.2 Allergy Treatment
5.6.3 Aesthetic Treatments
5.6.4 Hepatitis C
5.6.5 Haemophilia

6 Global Injectable Drug Delivery Market, By End User
6.1 Introduction
6.2 Home Care Settings
6.3 Hospitals and Clinics
6.4 Pharmaceutical and Biotechnology Companies
6.5 Research Laboratories
6.6 Other End Users

7 Global Injectable Drug Delivery Market, By Type
7.1 Introduction
7.2 Auto-injectors
7.2.1 Reusable Auto-injectors
7.2.2 Disposable Auto-injectors
7.2.3 Product Specific Auto-injectors
7.3 Pen Injectors
7.3.1 Custom Pen Designs
7.3.2 Disposable Pens
7.3.3 Dual Chamber Pens
7.3.4 Prefilled Pen Cartridges
7.3.5 Standardized Pen Platforms
7.4 Needle-free Injectors
7.4.1 Mass Immunization Injectors
7.4.2 Prefilled Disposable Models
7.4.3 Refillable Cartridge Designs
7.4.4 Energy Source
7.4.5 Jet-Based Needle-Free Injectors
7.4.6 Spring-Based Needle-Free Injectors
7.4.7 Laser-Powered Needle-Free Injectors
7.4.8 Vibration-Based Needle-Free Injectors
7.5 Prefilled Syringes
7.5.1 Plastic Prefilled Syringes
7.5.2 Glass Prefilled Syringes
7.5.3 Prefillable Safety Syringes
7.6 Safety Syringes
7.6.1 Prefillable Integrated Safety Syringes
7.6.2 Non-Prefillable Integrated Safety Syringes
7.7 Conventional Injection Devices

8 Global Injectable Drug Delivery Market, By Formulations
8.1 Introduction
8.2 Novel Drug Delivery Formulations
8.2.1 Colloidal Dispersions
8.2.1.1 Liposomes
8.2.1.2 Niosomes
8.2.1.3 Polymeric/Mixed Micelles
8.2.1.4 Nanoparticles
8.2.1.4.1 Nanosuspensions
8.2.1.4.2 Nanoemulsions/Microemulsions
8.2.1.4.3 Solid-Lipid Nanoparticles
8.2.2 Microparticles
8.2.2.1 Microspheres
8.2.2.2 Microcapsules
8.3 Long-Acting Injection Formulations
8.4 Conventional Drug Delivery
8.4.1 Solutions
8.4.2 Reconstituted/Lyophilized Formulations
8.4.3 Suspensions
8.4.4 Emulsions

9 Global Injectable Drug Delivery Market, By Mode of Administration
9.1 Introduction
9.2 Central Nervous System
9.3 Circulatory/Musculoskeletal
9.4 Organs
9.5 Skin

10 Global Injectable Drug Delivery Market, By Usage Pattern
10.1 Introduction
10.2 Curative Care
10.3 Immunization
10.4 Other Usage Patterns
10.4.1 Blood Transfusion & Blood Products
10.4.2 Contraceptives

11 Global Injectable Drug Delivery Market, By Geography
11.1 North America
11.1.1 US
11.1.2 Canada
11.1.3 Mexico
11.2 Europe
11.2.1 Germany
11.2.2 France
11.2.3 Italy
11.2.4 UK
11.2.5 Spain
11.2.6 Rest of Europe
11.3 Asia pacific
11.3.1 Japan
11.3.2 China
11.3.3 India
11.3.4 Australia
11.3.5 New Zealand
11.3.6 Rest of Asia Pacific
11.4 Rest of the World
11.4.1 Middle East
11.4.2 Brazil
11.4.3 Argentina
11.4.4 South Africa
11.4.5 Egypt

12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies

13 Company Profiling
13.1 Alkermes PLC
13.2 Baxter International, Inc.
13.3 Becton, Dickinson and Company
13.4 Elcam Medical
13.5 ELI Lilly and Company
13.6 Gerresheimer AG
13.7 Novo Nordisk
13.8 Pfizer, Inc.
13.9 Sandoz
13.10 Schott AG
13.11 Terumo Corporation
13.12 Teva Pharmaceutical Industries Ltd.

List of TaTable 1 Global Injectable Drug Delivery Market Outlook, By Region (2013-2022) ($MN)
Table 2 Global Injectable Drug Delivery Market Outlook, By Therapeutic Application (2013-2022) ($MN)
Table 3 Global Injectable Drug Delivery Market Outlook, By Autoimmune Diseases (2013-2022) ($MN)
Table 4 Global Injectable Drug Delivery Market Outlook, By Crohn’s Disease (2013-2022) ($MN)
Table 5 Global Injectable Drug Delivery Market Outlook, By Multiple Sclerosis (2013-2022) ($MN)
Table 6 Global Injectable Drug Delivery Market Outlook, By Psoriasis (2013-2022) ($MN)
Table 7 Global Injectable Drug Delivery Market Outlook, By Rheumatoid Arthritis (2013-2022) ($MN)
Table 8 Global Injectable Drug Delivery Market Outlook, By Other Autoimmune Diseases (2013-2022) ($MN)
Table 9 Global Injectable Drug Delivery Market Outlook, By Hormonal Disorders (2013-2022) ($MN)
Table 10 Global Injectable Drug Delivery Market Outlook, By Anaemia (2013-2022) ($MN)
Table 11 Global Injectable Drug Delivery Market Outlook, By Antithrombotic/Thrombolytic Therapy (2013-2022) ($MN)
Table 12 Global Injectable Drug Delivery Market Outlook, By Diabetes (2013-2022) ($MN)
Table 13 Global Injectable Drug Delivery Market Outlook, By Growth Hormone Deficiency (GHD) (2013-2022) ($MN)
Table 14 Global Injectable Drug Delivery Market Outlook, By Osteoporosis (2013-2022) ($MN)
Table 15 Global Injectable Drug Delivery Market Outlook, By Reproductive Health Disease (2013-2022) ($MN)
Table 16 Global Injectable Drug Delivery Market Outlook, By Orphan Diseases (2013-2022) ($MN)
Table 17 Global Injectable Drug Delivery Market Outlook, By Oncology (2013-2022) ($MN)
Table 18 Global Injectable Drug Delivery Market Outlook, By Other Therapeutic Applications (2013-2022) ($MN)
Table 19 Global Injectable Drug Delivery Market Outlook, By Pain Management (2013-2022) ($MN)
Table 20 Global Injectable Drug Delivery Market Outlook, By Allergy Treatment (2013-2022) ($MN)
Table 21 Global Injectable Drug Delivery Market Outlook, By Aesthetic Treatments (2013-2022) ($MN)
Table 22 Global Injectable Drug Delivery Market Outlook, By Hepatitis C (2013-2022) ($MN)
Table 23 Global Injectable Drug Delivery Market Outlook, By Haemophilia (2013-2022) ($MN)
Table 24 Global Injectable Drug Delivery Market Outlook, By End User (2013-2022) ($MN)
Table 25 Global Injectable Drug Delivery Market Outlook, By Home Care Settings (2013-2022) ($MN)
Table 26 Global Injectable Drug Delivery Market Outlook, By Hospitals and Clinics (2013-2022) ($MN)
Table 27 Global Injectable Drug Delivery Market Outlook, By Pharmaceutical and Biotechnology Companies (2013-2022) ($MN)
Table 28 Global Injectable Drug Delivery Market Outlook, By Research Laboratories (2013-2022) ($MN)
Table 29 Global Injectable Drug Delivery Market Outlook, By Other End Users (2013-2022) ($MN)
Table 30 Global Injectable Drug Delivery Market Outlook, By Type (2013-2022) ($MN)
Table 31 Global Injectable Drug Delivery Market Outlook, By Autoinjectors (2013-2022) ($MN)
Table 32 Global Injectable Drug Delivery Market Outlook, By Reusable Autoinjectors (2013-2022) ($MN)
Table 33 Global Injectable Drug Delivery Market Outlook, By Disposable Autoinjectors (2013-2022) ($MN)
Table 34 Global Injectable Drug Delivery Market Outlook, By Product Specific Autoinjectors (2013-2022) ($MN)
Table 35 Global Injectable Drug Delivery Market Outlook, By Pen Injectors (2013-2022) ($MN)
Table 36 Global Injectable Drug Delivery Market Outlook, By Custom Pen Designs (2013-2022) ($MN)
Table 37 Global Injectable Drug Delivery Market Outlook, By Disposable Pens (2013-2022) ($MN)
Table 38 Global Injectable Drug Delivery Market Outlook, By Dual Chamber Pens (2013-2022) ($MN)
Table 39 Global Injectable Drug Delivery Market Outlook, By Prefilled Pen Cartridges (2013-2022) ($MN)
Table 40 Global Injectable Drug Delivery Market Outlook, By Standardized Pen Platforms (2013-2022) ($MN)
Table 41 Global Injectable Drug Delivery Market Outlook, By Needle-free Injectors (2013-2022) ($MN)
Table 42 Global Injectable Drug Delivery Market Outlook, By Mass Immunization Injectors (2013-2022) ($MN)
Table 43 Global Injectable Drug Delivery Market Outlook, By Prefilled Disposable Models (2013-2022) ($MN)
Table 44 Global Injectable Drug Delivery Market Outlook, By Refillable Cartridge Designs (2013-2022) ($MN)
Table 45 Global Injectable Drug Delivery Market Outlook, By Energy Source (2013-2022) ($MN)
Table 46 Global Injectable Drug Delivery Market Outlook, By Jet-Based Needle-Free Injectors (2013-2022) ($MN)
Table 47 Global Injectable Drug Delivery Market Outlook, By Spring-Based Needle-Free Injectors (2013-2022) ($MN)
Table 48 Global Injectable Drug Delivery Market Outlook, By Laser-Powered Needle-Free Injectors (2013-2022) ($MN)
Table 49 Global Injectable Drug Delivery Market Outlook, By Vibration-Based Needle-Free Injectors (2013-2022) ($MN)
Table 50 Global Injectable Drug Delivery Market Outlook, By Prefilled Syringes (2013-2022) ($MN)
Table 51 Global Injectable Drug Delivery Market Outlook, By Plastic Prefilled Syringes (2013-2022) ($MN)
Table 52 Global Injectable Drug Delivery Market Outlook, By Glass Prefilled Syringes (2013-2022) ($MN)
Table 53 Global Injectable Drug Delivery Market Outlook, By Prefillable Safety Syringes (2013-2022) ($MN)
Table 54 Global Injectable Drug Delivery Market Outlook, By Safety Syringes (2013-2022) ($MN)
Table 55 Global Injectable Drug Delivery Market Outlook, By Prefillable Integrated Safety Syringes (2013-2022) ($MN)
Table 56 Global Injectable Drug Delivery Market Outlook, By Non-Prefillable Integrated Safety Syringes (2013-2022) ($MN)
Table 57 Global Injectable Drug Delivery Market Outlook, By Conventional Injection Devices (2013-2022) ($MN)
Table 58 Global Injectable Drug Delivery Market Outlook, By Formulations (2013-2022) ($MN)
Table 59 Global Injectable Drug Delivery Market Outlook, By Novel Drug Delivery Formulations (2013-2022) ($MN)
Table 60 Global Injectable Drug Delivery Market Outlook, By Colloidal Dispersions (2013-2022) ($MN)
Table 61 Global Injectable Drug Delivery Market Outlook, By Microparticles (2013-2022) ($MN)
Table 62 Global Injectable Drug Delivery Market Outlook, By Long-Acting Injection Formulations (2013-2022) ($MN)
Table 63 Global Injectable Drug Delivery Market Outlook, By Conventional Drug Delivery (2013-2022) ($MN)
Table 64 Global Injectable Drug Delivery Market Outlook, By Solutions (2013-2022) ($MN)
Table 65 Global Injectable Drug Delivery Market Outlook, By Reconstituted/Lyophilized Formulations (2013-2022) ($MN)
Table 66 Global Injectable Drug Delivery Market Outlook, By Suspensions (2013-2022) ($MN)
Table 67 Global Injectable Drug Delivery Market Outlook, By Emulsions (2013-2022) ($MN)
Table 68 Global Injectable Drug Delivery Market Outlook, By Mode of Administration (2013-2022) ($MN)
Table 69 Global Injectable Drug Delivery Market Outlook, By Central Nervous System (2013-2022) ($MN)
Table 70 Global Injectable Drug Delivery Market Outlook, By Circulatory/Musculoskeletal (2013-2022) ($MN)
Table 71 Global Injectable Drug Delivery Market Outlook, By Organs (2013-2022) ($MN)
Table 72 Global Injectable Drug Delivery Market Outlook, By Skin (2013-2022) ($MN)
Table 73 Global Injectable Drug Delivery Market Outlook, By Usage Pattern (2013-2022) ($MN)
Table 74 Global Injectable Drug Delivery Market Outlook, By Curative Care (2013-2022) ($MN)
Table 75 Global Injectable Drug Delivery Market Outlook, By Immunization (2013-2022) ($MN)
Table 76 Global Injectable Drug Delivery Market Outlook, By Other Usage Patterns (2013-2022) ($MN)
Table 77 Global Injectable Drug Delivery Market Outlook, By Blood Transfusion & Blood Products (2013-2022) ($MN)
Table 78 Global Injectable Drug Delivery Market Outlook, By Contraceptives (2013-2022) ($MN)

Note: All the regional tables including North America, Europe, Asia Pacific & Rest of World are represented same as above.

bles
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Alkermes PLC
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Elcam Medical
  • ELI Lilly and Company
  • Gerresheimer AG
  • Novo Nordisk
  • Pfizer, Inc.
  • Sandoz
  • Schott AG
  • Terumo
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll